This research report provides results from the study on living conditions
among people with disabilities in Malawi. Comparisons are made between
individuals with and without disabilities and also between households with and without a disabled family member. Results obtained in Malawi are also comp...ared those obtained in earlier studies carried out in Namibia and Zimbabwe. The Malawian study was undertaken in 2003.
more
This new edition and fully updated publication replaces the 2012 UCG and is being circulated free of charge to all public and private sector prescribers, pharmacists, and regulatory authorities in the country
Situation Analaysis and Needs Assessment
Almost 30 countries vulnerable to a new Ebola-style Epidemic, jeopardising the future of millions of Children. The report ranks the world’s poorest countries on the state of their public health systems, finding that 28 have weaker defences in place than Liberia where, alongside Sierra Leone and Gu...inea, the current Ebola crisis has already claimed 9,000 lives, and provoked an extraordinary international response to help contain it.
more
Enseignements tirés des derniers épisodes épidémiques d'Ebola pour guider la gestion des risques actuels Dar es Salaam, Tanzanie 1-2 Septembre 2014
Une réunion d’urgence a été organisée conjointement par le réseau d’Organisation pour la Surveillance Régionale des Maladies (CORDS), et ...le Centre de la Surveillance des Maladies Infectieuses de l’Afrique du Sud (SACIDS) afin de réunir et d’évaluer les expériences acquises au cours des épisodes épidémiques d'Ebola en Ouganda et en République démocratique du Congo (RDC) qui permettraient de guider la gestion des risques actuels
more
The WHO guidelines provide recommended steps for safe phlebotomy and reiterate accepted principles for drawing, collecting blood and transporting blood to laboratories/blood banks.
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of n...ucleos(t)ide analogues with a high barrier to drug resistance (tenofovir and entecavir, and entecavir in children aged 2–11 years) for first- and second-line treatment. Recommendations for the treatment of HBV/HIV-coinfected persons are based on the WHO 2013 Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, which will be updated in 2015.
more
Health Systems in Transition. Vol. 5 No.3 2015
Vulnerable and Marginalized Groups Planning Framework